Trial Profile

An Investigator Initiated, Pilot Study to Assess the Efficacy and Safety of DARE-BV1 (MP-101) in the Treatment of Bacterial Vaginosis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Aug 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clindamycin (Primary)
Indications Bacterial vaginosis
Focus Proof of concept; Therapeutic Use

Most Recent Events

20 Aug 2020 According to a Dare Biosciences media release, data from this study was published in the Clinical and Experimental Obstetrics & Gynecology journal.
20 Aug 2020 Results published in the Dare Bioscience media release.
08 Aug 2019 According to a Dare Bioscience media release, results from this study will be presented in a poster at the upcoming annual meeting of the Infectious Diseases Society for Obstetrics and Gynecology (8th-10th Aug, 2019).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com